Dialogue with the Experts: Diagnosing, Assessing, and Managing Inflammatory Rheumatic Disease
Medium: Video Roundtable
Commerical Support: This activity is supported by independent educational grants from AbbVie and Novartis.
Upon completion of this activity, participants will be able to:
- Describe specific clinical, laboratory, and imaging findings that can differentiate RA, PsA, and AS from each other and other similar conditions;
- Characterize RA, PsA, and AS in terms of disease severity and course;
- Review the most current evidence for a T2T approach for patients with RA, PsA, and AS;
- Discuss recent updates in RA, PsA, and AS treatment guidelines;
- Outline newly approved and investigational agents for RA, PsA, and AS that are likely to be incorporated into future standards of care for these conditions.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Assistant Professor of Medicine
Department of Rheumatology
Fellowship Program Director
Director of the Vasculitis Center
University of Chicago
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with anycommercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Chicago Pritzker School of Medicine and MCM Education. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.